Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors

Abstract

Signal transduction processes activated by Toll-like receptors (TLRs) include the important transcription factor NF-κB and 2 MAP kinases, p38 and Jun N-terminal kinase. These signals ultimately give rise to increased expression of a multitude of pro-inflammatory proteins. Receptor-proximal proteins involved in signalling by all TLRs include the adapter MyD88, 3 IRAKs (IRAK-4, IRAK and IRAK-2), Tollip, Traf-6 and TAK-1. Differences between signals generated by TLRs are emerging, with both TLR4 and TLR2 signalling requiring an additional adapter termed MyD88-adapter-like (Mal; also known as TIRAP). MyD88 and Mal both have a homologous Toll/IL-1 receptor (TIR) domain although they differ in their N-termini, with MyD88 possessing a death domain. In addition, structural models reveal marked differences in surface charges which, when taken with surface charge differences between TLR2 and TLR4 TIR domains, may indicate that TLR4 but not TLR2 recruits Mal directly. Another difference is that Mal can become phosphorylated. Future studies on Mal will reveal specificities in signal transduction by different TLRs, which may ultimately provide molecular explanations for specificities in the innate immune response to infection.

References

Poltorak A. , He X. , Smirnova I. et al. Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085—2088.

Hoshino K. , Takeuchi O. , Kawai T. et al. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749—3752.

Qureshi ST , Lariviere L. , Leveque G. et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999; 189: 615—625.

Wesche H. , Henzel WJ , Shillinglaw W. , Li S. , Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997; 7: 837—847.

Burns K. , Martinon F. , Esslinger C. et al. MyD88: an adapter protein involved in interleukin-1 signaling . J Biol Chem 1998; 273: 12203—12209.

Medzhitov R. , Preston-Hurlburt P. , Kopp E. et al. MyD88 is an adapter in the hToll/IL-1 receptor family signalling pathways. Mol Cell 1998; 2: 253—258.

Cao Z. , Henzel WJ , Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science 1996; 271: 1128—1131.

Suzuki N. , Suzuki S. , Duncan GS et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002; 416: 750—756.

Li S. , Strelow A. , Fontana EJ , Wesche H. IRAK-4: a novel member of the IRAK family with the properties of an IRAKkinase . Proc Natl Acad Sci USA 2002; 99: 5567—5572.

10.

Muzio M. , Ni J. , Feng P. , Dixit VM IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997; 278: 1612—1615.

11.

Wesche H. , Gao X. , Li X. , Kirschning CJ , Stark GR , Cao Z. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem 1999; 274: 19403—19410.

12.

Cao Z. , Xiong J. , Takeuchi M. , Kurama T. , Goeddel DV Traf-6 is a signal transducer for interleukin-1. Nature 1996; 383: 443—446.

13.

Wang C. , Deng L. , Hong M. , Akkaraju GR , Inoue J. , Chen ZJ TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412: 346—351.

14.

O'Neill Laj. Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends Immunol 2001; 23: 296—300.

15.

Adachi O. , Kawai T. , Takeda K. et al. Targeted disruption of the MyD88 gene results in loss of IL-1 and IL-18-mediated function. Immunity 1998 ; 9: 143—150.

16.

Kawai T. , Adachi O. , Ogawa T. , Takeda K. , Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999; 11: 115—150.

17.

Thomas JA , Allen JL , Tsen M. et al. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J Immunol 1999; 163: 978—984.

18.

Naito A. , Azuma S. , Tanaka S. et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 1999; 4: 353—362.

19.

Kaisho T. , Takeuchi O. , Kawai T. , Hoshino K. , Akira S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol 2001; 166: 5688—5694.

20.

Kawai T. , Takeuchi O. , Fujita T. et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 2001; 167: 5887—5894.

21.

Fitzgerald KA , Palsson-McDermott EM , Bowie AG et al. Mal (MyD88 adapter-like) is required for TLR4 signal transduction. Nature 2001; 413: 78—83.

22.

Horng T. , Barton GM , Medzhitov R. TIRAP: an adapter molecule in Toll signalling. Nat Immunol 2001; 2: 835—841.

23.

Toshchakov V. , Jones BW , Perera PY et al. TLR4, but not TLR2, mediates IFN-beta-induced STAT1 alpha/beta-dependent gene expression in macrophages. Nat Immunol 2002; 3: 392—398.

24.

Xu Y. , Tao X. , Shen B. et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 2000; 408: 111—115.

25.

Re F. , Strominger JL Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001; 276: 37692—37699.

26.

Pulendran B. , Kumar P. , Cutler CW , Mohamadzadeh M. , Van Dyke T. , Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 2001; 167: 5067—5076.

27.

Hirschfeld M. , Weis JJ , Toshchakov V. et al. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 2001; 69: 1477—1482.

28.

Shinobu N. , Iwamura T. , Yoneyama M. et al. Involvement of TIRAP/MAL in signaling for the activation of interferon regulatory factor 3 by lipopolysaccharide. FEBS Lett 2002; 517: 251—256.